Fortrea Holdings (FTRE) Interest Coverage Ratio (2022 - 2023)
Fortrea Holdings' (FTRE) quarterly Interest Coverage Ratio came in at 0.7 in Q4 2023, down 100.97% on a YoY basis from 71.5 in Q4 2022, and down 333.69% quarter-over-quarter from 0.3 in Q3 2023.
Powered by 
Analysis
Fortrea Holdings (FTRE) Interest Coverage Ratio (2022 - 2023) Analysis & Trends
Fortrea Holdings (FTRE) has reported Interest Coverage Ratio for 2 consecutive years, with 0.7 the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Interest Coverage Ratio fell 100.97% year-over-year to 0.7; the trailing twelve-month figure through Dec 2023 stood at 0.46 (changed N/A YoY), and the FY2023 full-year result was 0.46, down 99.95% from the prior year.
- Interest Coverage Ratio slipped to 0.7 in Q4 2023 per FTRE's latest filing, from 0.3 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 71.5 in Q4 2022 and bottomed at 0.7 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 2.57 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.83 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 3.95 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -689.75 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -0.70 |
| Sep 30, 2023 | 0.30 |
| Jun 30, 2023 | 45.14 |
| Dec 31, 2022 | 71.50 |